AL
Alzamend Neuro Inc
ALZN · NASDAQ
$1.94 +0.52% (+$0.01)
1M +21.25%
Market Cap $7.38M
P/E Ratio -
Div. Yield -
ROE 277.88%
Bulios Fair Price
$1.6
17.5% downside
Trenutna cena
$1.94
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica ALZN trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/B 1.27x
P/E N/A
EV/FFO N/A
Growth
0 /100
Declining Book val. growth 37.79%
EPS growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 156.69%
Asset turnover 0.00x
ROE 277.88%
Debt
100 /100
Low Debt/Equity 0.00x
Int. coverage 546.20x
Current ratio 3.01x
Stability
31 /100
Unstable Beta 0.19x
Profitable years 0
EPS volatility 28.87%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ALZN
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Stephan Jackman
Employees
6
Headquarters
Atlanta
Prihajajoči dogodki
08 DEC.
Earnings
Upcoming earnings report